Docoh
Loading...

LH Laboratory Corp. Of America

Employees

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

ESG term mentions

In last year of SEC filings
AgricultureAirCarbonCarbon EmissionsCarbon FootprintConflict MineralsEcologyEnvironmentEnvironmentalExtractionLand useLandfillLEEDLife CycleMaterialsNatural ResourcesNatureOffsetPackagePandemicRegenerativeRenewableScenario AnalysesToxicWasteWaterWater UsageWildlifeWindAccessAsianBenefitsBlackCalifornia Consumer Privacy ActCharitableCharityChild LaborCollective BargainingCommunityCultureCustomerCyberCybersecurityData PrivacyData SecurityDeathDemographicDemographicsDisabilityDiversityDiversity and InclusionEmployeeEmployee Resource GroupEmployee TrainingEngagementEthnicEthnicityGenderGeneral Data Protection RegulationHealth and SafetyHealth CareHealthcareHiringHispanicHuman CapitalHuman ResourcesHuman RightsHuman TraffickingIncidentInjuryLabor practiceLabor StandardsLGBTQMinimum WageMinorityOpioidOSHAOvertimePay for PerformancePerquisitesPrivacyRecallRecruitRecruitmentReimbursementRetentionRetirementSafetySatisfactionSkillSkilledSkillsSocialSocietyStakeholderSupplierSupplier DiversitySupply ChainSupply Chain ManagementTalentTrainingUnionUnionizedWomenWorkersWorkforceWorking ConditionWorkplace SafetyAction PlanActivistAnti-corruptionAntitrustAssessmentAssuranceAttorney GeneralAttorneys GeneralAuditBoard OversightBoard RefreshmentBonusBriberyChronicClass Action LawsuitClassifiedClawbackCommitmentConflict of InterestCorporate GovernanceCorporate PurposeCorruptionDepartment ofEnterprise Risk ManagementESGEthicsExecutive CompensationExpertFraudGoalsGovernanceHedgingIncentiveIncentivizeIndependenceIndependentInnovationInnovativeInvestigationLawsuitLead Independent DirectorLeadershipLitigationLong-termMajorityMissionOther Public Company BoardsOverboardingOverseeOversightPerquisitePlaintiffPledgingProcurementProxy AccessPurposeQuality StandardR&DReputationReputationalResearch and DevelopmentResponsibilityResponsibleRight to Call a Special MeetingRight to Call Special MeetingsShareholder EngagementShareholder ProposalsSpecial MeetingStrategySustainabilitySustainableTargetsTaxTenureTransparencyTransparent

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
The 2021 Annual Meeting of Shareholders (the “Annual Meeting”) of Laboratory Corporation of America Holdings (the “Company”) was held on May 12, 2021. As of March 24, 2021, the date of record for determining the Company’s shareholders entitled to vote on the proposals presented at the Annual Meeting, there were 97,640,861 shares of the Company’s common stock issued and outstanding and entitled to vote at the Annual Meeting. The holders of 86,897,605 shares of the Company’s issued and outstanding common stock were represented in person or by proxy at the Annual Meeting, constituting a quorum. The proposals presented at the Annual Meeting are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 2, 2021 (the “Proxy Statement”). The vote results detailed below represent final results as certified by the Inspector of Elections.

Proposal 1.

The Company’s shareholders elected the following persons, who were listed in the Proxy Statement, to the Board to hold office for the term expiring at the 2022 Annual Meeting of Shareholders or until their successors are elected and qualified or until their earlier death, resignation, or removal:

Votes ForVotes
Against
AbstentionsBroker
Non-Votes
Adam H. Schechter73,328,9805,394,024605,5537,569,048
Kerrii B. Anderson71,597,1497,686,66444,7447,569,048
Jean-Luc Bélingard75,027,4174,254,72546,4157,569,048
Jeffrey A. Davis78,747,054533,94147,5627,569,048
D. Gary Gilliland, M.D., Ph.D.78,777,649463,08787,8217,569,048
Garheng Kong, M.D., Ph.D.73,929,0275,353,46646,0647,569,048
Peter M. Neupert70,817,3978,461,86949,2917,569,048
Richelle P. Parham78,234,0211,048,83045,7067,569,048
Kathryn E. Wengel79,166,291119,09143,1757,569,048
R. Sanders Williams, M.D.74,258,8644,982,19787,4967,569,048


Proposal 2.

The Company’s shareholders approved, in an advisory (non-binding) vote, the compensation of the Company’s named executive officers. The votes regarding this proposal were as follows:

Votes ForVotes
Against
AbstentionsBroker
Non-Votes
72,236,8476,915,431176,2797,569,048


Proposal 3.

The Company’s shareholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021. The votes regarding this proposal were as follows:

Votes ForVotes
Against
AbstentionsBroker Non-
Votes
85,261,7701,587,45548,3800


Proposal 4.

The Company’s shareholders voted against the shareholder proposal seeking an amendment to the Company’s proxy access by-law to remove the aggregation limit. The votes regarding this proposal were as follows:

Votes ForVotes
Against
AbstentionsBroker Non-
Votes
29,709,38549,415,648203,5247,569,048